Kappa Bioscience, producer of K2VITAL® vitamin K2 MK-7, is the pioneer in development and production of exceptionally pure all-trans menaquinone-7 by organic synthesis. K2VITAL® is 99.7% biologically active MK-7 produced in Kappa’s GMP-certified Norwegian facility. Protected, microencapsulated K2VITAL® DELTA is Kappa's market-leading solution to K2 stability and compliant consumer products. Unprotected K2 is not stable when formulated with minerals, and DELTA ensures stability, quality and delivery on label claim. The K2VITAL® product portfolio offers a full range of formats and concentrations designed to support innovative dose, formulations and product success. 

Vitamin K2 MK-7 is an essential vitamin that balances calcium in the body. K2VITAL® supports Bone Health by activating osteocalcin proteins that integrate corporate calcium to bone, and Cardiovascular Health by activating matrix-Gla proteins (MGP) which prevent excess calcium from deposit in the heart and arteries. K2VITAL® puts calcium in balance.   

Innovative Kappa solutions such as the K2 Formulation LookBook and ExperienceCard white-label concepts speed time-to-market and success. K2VITAL® is the Perfect Pair partner to vitamin D3, and improves products designed for all consumer types. 

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Contact information




View All Contact Info